# GLYKO BIOMEDICAL LTD

GLYKO BIOMEDICAL LTD is a company headquartered in Novato, CA, United States.

## Company overview

- **Legal name:** GLYKO BIOMEDICAL LTD
- **Classification:** Company
- **Industry (SIC):** 2835 — In Vitro & In Vivo Diagnostic Substances
- **Headquarters:** Novato, CA, United States
- **Fiscal year end:** December 31
- **SEC CIK:** 0000908401

## About

GLYKO BIOMEDICAL LTD is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000908401, and its reported industry is In Vitro & In Vivo Diagnostic Substances. The retained history contains 12 filings, including 8-K filed on 2002-08-22. Each filing retains its accession, filing date and original SEC document link. This historical evidence does not establish current registration, listing, ownership or financial condition.

## Recent SEC filings

- Form 8-K — filed 2002-08-22 — period 2002-08-22 — 8-K
- Form 10-Q — filed 2002-08-20 — period 2002-06-30 — GBL 10Q JUNE 30, 2002
- Form 8-K — filed 2002-08-19 — period 2002-08-19 — FORM 8-K
- Form 8-K — filed 2002-08-14 — period 2002-08-14 — 8-K
- Form 8-K — filed 2002-07-01 — period 2002-06-27 — FORM 8-K
- Form 10-Q — filed 2002-05-15 — period 2002-03-31 — GBL 10-Q 03/31/02
- Form 8-K — filed 2002-05-03 — period 2002-04-26 — 8-K
- Form 8-K — filed 2002-04-04 — period 2002-04-02 — 8-K
- Form 8-K — filed 2002-04-02 — period 2002-03-28 — FORM 8-K
- Form 10-K — filed 2002-04-01 — period 2001-12-31 — BODY OF 10-K FOR GBL 12/31/01
- Form 8-K — filed 2002-02-14 — period 2002-02-06 — 8-K
- Form SC 13G — filed 2001-12-10 — SCHEDULE 13G

---

Updated: 2026-10-23T22:24:09Z

Canonical page: https://altss.com/profile/glyko-biomedical-ltd

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology